BioCentury
ARTICLE | Clinical News

TPM/oxymorphone patch: Phase I data

November 11, 2013 8:00 AM UTC

An Australian Phase I trial showed that all 12 healthy volunteers who received the first application of Phosphagenics' 3-day TPM/oxymorphone patch achieved oxymorphone plasma concentrations above thre...